PlainPharmaWatch

CMS Open Payments · Program Year 2024

AnX Robotica Corp

AnX Robotica Corp reported $45,922.49 across General Payments, Research, and Ownership to 69 physicians and teaching hospitals across 70 transactions.

$45.9K
All-tracks total
70
Transactions
69
Recipients
−$5.7K
General Payments vs PY2023

AnX Robotica Corp reported $45,922.49 across all CMS Open Payments tracks (General + Research + Ownership) to 69 physicians and teaching hospitals in Program Year 2024 - ranking #1371 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $31,629.49, averaging $665.54 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer anx-robotica-corp AnX Robotica Corp

$45.9K · #1371/1,925 · 0.0% industry · PY2024

  • TOT $45.9K
  • RANK #1371
  • SHARE 0.0%
  • TXN 70
  • RCP 69
  • CAT 3
  • GEN $31.6K
  • ΔGEN −$5.7K
  • TOP1 66.4%
  • PY 2024

Nearest volume peer: Curium US LLC ($45.9K)

HF Acquisition Co. LLC$46.1KMeisinger USA, LLC$46.0KAnX Robotica Corp (this)$45.9KCurium US LLC$45.9KHartmann USA, Inc.$45.9K
All-tracks payment totals near AnX Robotica Corp (CMS Open Payments PY2024)

AnX Robotica Corp sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

AnX Robotica Corp's CMS-reported General Payments decreased by $5.7K (−15.3%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: ANX ROBOTICA CORPPY2023: ANX ROBOTICA CORPPY2024: AnX Robotica Corp. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$37.3KPY2024$31.6K
PY2023
$37,347.85
PY2024
$31,629.49

What the Data Shows for AnX Robotica Corp

Rank #1371 of 1,925 companies in CMS Open Payments for 2024 belongs to AnX Robotica Corp, which reported $45,922.49 across 70 transactions to 69 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $656.04 per transaction and $665.54 per recipient.

Of the 3 general-payment categories charted below, "Consulting Fee" is the largest at $23.0K across 14 transactions, 72.7% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 3 types of general payments, AnX Robotica Corp's largest category was "Consulting Fee" at $23.0K - 72.7% of General Payments.

How AnX Robotica Corp divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$23.0K2. Food and Beverage$7.1K3. Compensation for Services…$1.5K
Payment Type Amount Transactions
Consulting Fee $23.0K 14
Food and Beverage $7.1K 54
Compensation for Services Other Than Consulting $1.5K 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $25,800.38 (81.6%) of $31,629.49 in this company's General Payments records across 45 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for AnX Robotica Corp

The five named recipients with the highest reported General Payments from this company

Joel Brill$21.0KDavid Poppers$2.0KKenneth Joseph Brown$1.2KJay Yepuri$1.2KMichael Smith$409.21
  1. 1

    Joel Brill

    $21,000.00 across 12 reported transactions

  2. 2

    David Poppers

    $2,026.97 across 5 reported transactions

  3. 3

    Kenneth Joseph Brown

    $1,182.10 across 2 reported transactions

  4. 4

    Jay Yepuri

    $1,182.10 across 2 reported transactions

  5. 5

    Michael Smith

    $409.21 across 3 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as AnX Robotica Corp's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about AnX Robotica Corp.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with AnX Robotica Corp.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download AnX Robotica Corp's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.